Table 3.

Comparative response of subgroups

EtiologyVigabatrinACTH
Initial12 moInitial12 mo
Symptomatic8 /115 /118 /93 /9
Cryptogenic4 /62 /67 /92 /9
Idiopathic4 /44 /43 /33 /3